Lupin eyes incremental revenues with Locoid co-promotion deal
This article was originally published in Scrip
Executive Summary
Lupin is to co-promote the US firm Onset Dermatologics' eczema therapy, Locoid Lotion (hydrocortisone butyrate 0.1%), to pediatricians in the US.